SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Stocks Crossing The 13 Week Moving Average <$10.01 -- Ignore unavailable to you. Want to Upgrade?


To: James Strauss who wrote (10955)4/29/2002 1:52:21 PM
From: Bucky Katt  Read Replies (1) | Respond to of 13094
 
Jim, one problem with being a service economy, and that is it will lower our standard of living over time.
If everyone is "sevicing an account" who is actually making stuff?

Information services, software development?
India can do it for a fraction of US worker cost, and if that gets expensive, Russia has some of the best computer brains...And they are even cheaper!

We do need more landscapers/gardeners though.........Hey, a US growth industry, as people here are so lazy they can't do yard work anymore, which will eventually lead back to my bio-medical-health care rats.....As the fat & sickly keel over...



To: James Strauss who wrote (10955)4/29/2002 4:28:38 PM
From: Bucky Katt  Read Replies (1) | Respond to of 13094
 
PKI has some exciting news>
PerkinElmer Awarded U.S. Patent for Industry-Leading Microarray Innovation
BOSTON--(BW HealthWire)--April 29, 2002--PerkinElmer, Inc. (NYSE: PKI - news), a leading provider of drug discovery, life science research and genetic disease screening solutions, today announced that the U.S. Patent and Trademark Office has issued the Company patent number 6,355,934 for all claims relating to an "Imaging System for an Optical Scanner." This patent covers the use of the Company's geometric beamsplitter, an integral component of the optical design for PerkinElmer Life Sciences' ScanArray® Express fluorescence scanning system. This laser scanner technology offers wavelength flexibility, ensuring upgradeability and application flexibility unmatched by other scanning technologies in the industry. With this patent, PerkinElmer Life Sciences continues to solidify its leadership position in microarray scanning technology.

All scanning-laser microarray scanners require a beamsplitter that causes the excitation beam to be directed to the sample while allowing the fluorescence beam to travel toward the detector. The fundamental design of PerkinElmer Life Sciences' patented geometric beamsplitter allows for efficient light delivery and collection for many wavelengths and delivers signal-to-noise ratio that is five times higher than traditional designs.

"The ScanArray Express is the cornerstone of PerkinElmer Life Sciences' microarray instrumentation platform, and this patent preserves our ability to provide customers with the industry's leading signal-to-noise performance and wavelength flexibility," said Dr. Neil Cook, vice president, Global Research & Development, and chief scientific officer, PerkinElmer Life Sciences. "Innovations such as the beamsplitter have enabled PerkinElmer Life Sciences to maintain the industry-leading position in microarray imaging since its inception."

VISG taking on water, as you predicted...



To: James Strauss who wrote (10955)4/29/2002 8:42:34 PM
From: Bucky Katt  Read Replies (2) | Respond to of 13094
 
Trouble in real-estate lala land>

Real Estate Investor Sam Zell Runs Into Rough Spot (Update5)
By Robert Burgess

Chicago, April 29 (Bloomberg) -- Chicago billionaire Sam Zell built a fortune acquiring properties from financially distressed sellers and turning them around. Now, the self-described ``grave dancer'' is in a tough spot of his own.

His Equity Office Properties Trust is the worst performer in the 21-member Bloomberg Office REIT Index. A dollar invested in the largest office building owner at the start of the year has shrunk 4.08 percent, while the index has returned 3.72 percent.

The lagging performance follows an $11.8 billion West Coast expansion in 2000 and 2001, as the office-property market was peaking. Equity Office has since lost a key tenant at its largest development, Zell's chief executive quit this month, and the chief financial officer's spot has gone unfilled for six months.

Zell, the company's 60-year-old chairman, hosted a conference call today to discuss first-quarter earnings and tried to reassure investors he can still turn around a bad situation. The priority, he said, is to insulate the company from further declines in its markets and hire a chief executive whose skills lie more in managing businesses than acquiring property.

``To his credit, Zell clearly laid out the company's objectives, but those objectives are formidable hurdles,'' said Joe Smith, who helps manage more than $1 billion, including shares of Equity Office, at Clarion CRA Securities LP.

Equity Office's shares fell 4 cents to $28.38 on the New York Stock Exchange.

Earnings

The company's funds from operations -- a measure of cash flow used by REITs -- rose to $410.6 million, or 87 cents a share, from $272.6 million, or 78 cents, a year earlier. Results include a fee of $40 million, or 8 cents a share, paid by Sun Microsystems Inc. for not moving into a building at Equity Office's $223 million Foundry Square project in San Francisco.

``I was out there on the West Coast this month, and what I saw was worse than I expected,'' said James Sullivan, a REIT analyst at Prudential Financial who cut his rating on Equity Office this month to ``hold'' from ``buy.'' ``High-tech markets appear to be facing a protracted period of high vacancy.''

Zell has a lot at stake. He controls a 4.5 percent of Equity Office, a holding valued at about $378 million. Although he draws no salary, his stake collects about $26.5 million a year in dividends.

``I can assure you we have a talented management team in place,'' Zell said on the call. ``As I have said before, it's going to be a tough year but by the end of the year you're going to see significant positive news'' on the economy and real estate markets.

Chicago-based Equity Office owns 768 buildings across the U.S., including New York's Worldwide Plaza, the tower that houses Chicago's Mercantile Exchange, and Rowe's Wharf in Boston. It owns more than 125 million square feet of office space, more than twice as much as its nearest competitor, Toronto-based TrizecHahn Corp., whose stockholders this month approved its conversion to a U.S.- based REIT.

Zell built his reputation buying real estate in the late 1980s and early 1990s, when foreclosures were rising. The bet turned out right when the real estate market recovered faster than expected and vacancy rates hit all-time lows in 1999.

`We Pulled Back'

The executive, who leads a group of friends who refer to themselves as ``Zell's Angels'' on motorcycle junkets around the world, strayed from his bottom-fishing investment style last year. Equity Office bought developer Ned Spieker's Menlo Park, California-based Spieker Properties for $7.2 billion.

The purchase, about a year after Zell paid $4.6 billion for another REIT with a West Coast focus, Cornerstone Properties Inc., came when vacancy rates were at all-time lows of less than 3 percent in such places as San Francisco, San Jose and Seattle.

``Ned Spieker knows the West Coast better than anyone, and when he sold out to Zell, we pulled back on our Equity Office holdings,'' said Richard Imperiale, who helps manage about $1.4 billion for Forward Funds Inc.

Since the purchase, vacancy rates in San Francisco, Boston, San Jose and Seattle, which account for 45 percent of Equity Office's net operating income, have risen to more than 14 percent, and rents are down more than 20 percent, according to Torto Wheaton Research, a real-estate research firm.

`Legendary Investor'

Job growth in Equity Office's top four markets, after exceeding the national average through the 1990s, is expected to perform in line with the rest of the country in the next four years, according to Property and Portfolio Research.

``There's going to be some continued questions on the timing of the Spieker acquisition,'' said Clarion's Smith.

It is critical for Zell to prove he can manage as well as acquire properties, analysts said. Because of Equity Office's large size, a $1 billion acquisition would add just 4 cents a share to annual earnings, according to Sullivan.

``Zell is a legendary investor and a great dealmaker, but he's not known as a great operator,'' he said.

Making Zell's job tougher is the resignation on April 19 of Timothy Callahan, who had been president and chief executive of Equity Office since it went public in 1997, for ``personal reasons.'' The company has been searching for a chief financial officer for six months after promoting Richard Kincaid to chief operating officer.

In an interview on the day of Callahan's resignation, Zell declined to elaborate on Callahan's reasons for leaving, though he said it had nothing to do with the performance of the company. A new chief executive may be named by November, Sell said today.